Reports for SANDOZ IRBESARTAN HCT

Brand name

SANDOZ IRBESARTAN HCT

Company Name
SANDOZ CANADA INCORPORATED
Drug Identification Number
02337428
Ingredients
HYDROCHLOROTHIAZIDE
IRBESARTAN
Ingredient Strength
12.5 MG
150 MG
ATC Code
C09DA
C09DA
ATC Descriptor
ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Status
MARKETED
Shortage reports
Brand name Packaging Size Status Date Created Date Updated Reports
SANDOZ IRBESARTAN HCT 100 Resolved 2019-01-21 2020-07-20 73141
SANDOZ IRBESARTAN HCT 500 Resolved 2019-01-21 2020-07-20 73144
SANDOZ IRBESARTAN HCT 100FCT BO CA Resolved 2020-09-21 2020-10-27 124600
SANDOZ IRBESARTAN HCT 500FCT BO CA Resolved 2020-09-21 2020-10-27 124606
SANDOZ IRBESARTAN HCT 500 FCT BO Resolved 2020-11-27 2020-12-09 129102
SANDOZ IRBESARTAN HCT 500FCT BO CA Resolved 2021-01-12 2021-03-08 131394
SANDOZ IRBESARTAN HCT 100FCT Resolved 2023-03-13 2023-04-18 186967
SANDOZ IRBESARTAN HCT 500FCT Resolved 2023-03-13 2023-05-03 186971
SANDOZ IRBESARTAN HCT 100 FCT BO Resolved 2023-11-06 2023-12-12 209216
SANDOZ IRBESARTAN HCT 500FCT Resolved 2024-01-03 2024-02-19 214777

Showing 1 to 10 of 10

Discontinuation reports
Brand name Packaging Size Status Date Created Date Updated Reports

Showing 1 to 0 of 0